Percutaneous Renal Denervation in Treatment of Non-Hypertensive Diseases
In recent years,renal denervation(RDN),as a minimally invasive intervention treatment,interrupts renal sympathetic nerve activity by disrupting the sympathetic nerve located near the renal artery,blocking bidirectional signal transmission between the kidney and central sympathetic nervous system,and significantly and safely reducing blood pressure in hypertensive patients.The renal sympathetic nerve not only plays an important role in hypertension,but also plays a crucial role in cardiovascular diseases such as arrhythmia and heart failure,non cardiovascular diseases such as obstructive sleep apnea,metabolic disease and chronic kidney disease.RDN is expected to become an upstream treatment for various diseases.This article provides a review of RDN for the treatment of non-hypertensive diseases.